IP Verse

Alexion Pharmaceuticals vs. Amgen N.V. - ACT_13886/2024

Explore detailed information on the case number ACT_13886/2024 involving Alexion Pharmaceuticals and Amgen N.V., Amgen Biofarmaceutica Lda., Amgen Gmbh, and others which was filed on 19 Mar, 2024.

Case Details

    Case Number:

    ACT_13886/2024

    Patent Number:

    EP3167888

    Filing Date:

    19 Mar, 2024

    Proceeding Type:

    Proceeding

    Action/Application:

    Application For Provisional Measures

    Decision Date:

    26 Jun, 2024

    Plaintiffs:

    • Alexion Pharmaceuticals, Inc. Represented By Elena Hennecke

    Defendants:

    • Amgen N.V. Represented By Tilman Muller-Stoy
    • Amgen Biofarmaceutica Lda. Represented By Tilman Muller-Stoy
    • Amgen Gmbh Represented By Tilman Muller-Stoy
    • Amgen S.A.S. Represented By Tilman Muller-Stoy
    • Amgen Zdravila D.O.O. Represented By Tilman Muller-Stoy
    • Amgen Technology (Ireland) Unlimited Company Represented By Tilman Muller-Stoy
    • Amgen Ab Represented By Tilman Muller-Stoy
    • Amgen S.R.L. Represented By Tilman Muller-Stoy

    Judges:

    • Alima Zana
    • Rudi Goedeweeck
    • Sabine Klepsch
    • Stefan Schilling

    Court Division:

    First Instance, Local Division - Hamburg

Case Decision

Jun 26, 2024
Document

More cases on EP3167888B1

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Jul 31, 2025
Case NumberPlaintiffsDefendants
ACT_13849/2024Alexion PharmaceuticalsSamsung Bioepis Nl B.V.
APL_40470/2024Alexion PharmaceuticalsSamsung Bioepis Nl B.V.
APL_40553/2024Alexion PharmaceuticalsAmgen Technology (Ireland) Unlimited Company, Amgen N.V., Amgen Gmbh, Amgen Ab, Amgen S.A.S., Amgen S.R.L., Amgen Biofarmaceutica Lda., Amgen Zdravila D.O.O.
ACT_59173/2024Amgen Switzerland Ag Vilniaus FilialasAlexion Pharmaceuticals

More cases on Alexion Pharmaceuticals

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Jul 31, 2025
Case NumberPlaintiffsDefendants
APL_40470/2024Alexion PharmaceuticalsSamsung Bioepis Nl B.V.
App_8339/2025Alexion Pharmaceuticals -
APL_40553/2024Alexion PharmaceuticalsAmgen Technology (Ireland) Unlimited Company, Amgen N.V., Amgen Gmbh, Amgen Ab, Amgen S.A.S., Amgen S.R.L., Amgen Biofarmaceutica Lda., Amgen Zdravila D.O.O.

More cases on Amgen N.V.

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Jul 31, 2025
Case NumberPlaintiffsDefendants
APL_40553/2024Alexion PharmaceuticalsAmgen Technology (Ireland) Unlimited Company, Amgen N.V., Amgen Gmbh, Amgen Ab, Amgen S.A.S., Amgen S.R.L., Amgen Biofarmaceutica Lda., Amgen Zdravila D.O.O.
ACT_597355/2023Sanofi Biotechnologies Sas, Regeneron Pharmaceuticals Inc.Amgen Inc., Amgen Gmbh, Amgen Europe B.V., Amgen Nv, Amgen S.R.L., Amgen B.V., Amgen S.A.S.
ACT_10334/2025Regeneron Pharmaceuticals Inc., Sanofi Biotechnology SasAmgen S.R.L., Amgen S.A.S., Amgen Nv, Amgen Gmbh, Amgen Inc., Amgen Europe B.V., Amgen B.V.